SSO2 Therapy is a novel therapy that complements PCI for treating an acute heart attack.
Employees: 11-50
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Aperture V... | aperturevp... |
Mentions in press and media 8
| Date | Title | Description |
| 18.06.2019 | Zoll Medical Acquires TherOx | Zoll Medical Corporation, a Chelmsford, MA-based Asahi Kasei Group Company that manufactures medical devices and related software solutions, acquired TherOx, Inc., an Irvine, Calif.-based company focused on improving treatment of acute myoc... |
| 15.05.2018 | TherOx Finds Debt Funding | Irvine-based medical device company TherOx, which is developing medical devices to treat acute myocardial infarction (AMI), recently announced it has received a debt financing. The financing came from its existing investors, ZOLL Medical Co... |
| 11.08.2015 | TherOx rebounds from discarded IPO with new, $23M round for its device that speeds up heart attack recovery | But investors are still rallying around the long-standing company, as reflected in this fairly hefty fundraise. Its investigational device could, after all, impact a wide market: Heart attack patients. Its “super-saturated oxygen therapy” i... |
| 29.11.2013 | Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | Here’s how: Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The Super... |
| 21.02.2008 | Life sciences briefing: Thursday, Feb. 21, 2008 | TODAY’S HEADLINES: Compact ultrasound maker Zonare Medical raises $30M (VentureWire) TherOx raises $30M for hypersaturated-oxygen devices (peHUB) Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release) Population Genetics tak... |
| 21.02.2008 | TherOx raises $30M for hypersaturated-oxygen devices | See our coverage of this Irvine, Calif., maker of devices for treating heart attacks in today’s daily briefing at VentureBeat Life Sciences. VentureBeat VentureBeat's mission is to be a digital townsquare for technical decision makers to ga... |
| - | TherOx rebounds from discarded IPO with new, $23M round for its device that speeds up heart attack recovery | TherOx, the maker of a device that could quickly salvage damaged heart tissue after a heart attack, is in the midst of a sizable equity round — its largest since it a failed IPO attempt during the recession and a snub from the FDA. TherOx j... |
| - | Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized “super-saturated oxygen” (SSO2) offers a ... |